Stocks and Investing Stocks and Investing
Mon, January 3, 2022
[ 12:00 AM ] - WOPRAI
Dara Mohsenian Maintained (STZ) at Buy with Increased Target to $303 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Andrea Teixeira Maintained (STZ) at Buy with Increased Target to $283 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Steve Powers Maintained (STZ) at Hold with Increased Target to $240 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TSLA) at Hold with Increased Target to $335 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Ryan Brinkman Maintained (TSLA) at Sell with Increased Target to $98 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Emmanuel Rosner Maintained (TSLA) at Strong Buy with Increased Target to $400 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Adam Jonas Maintained (TSLA) at Buy on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Garrett Nelson Upgraded (TSLA) to Strong Buy on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jason Goldberg Downgraded (USB) to Hold and Held Target at $68 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
David George Maintained (USB) at Hold and Held Target at $55 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (VFC) at Buy and Held Target at $85 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Bernie McTernan Initiated (VCSA) at Strong Buy and Held Target at $260 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (VTR) at Strong Buy with Decreased Target to $64 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (WELL) at Strong Buy with Increased Target to $103 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Harsh Kumar Upgraded (WOLF) to Buy and Increased Target to $160 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jason Goldberg Upgraded (WFC) to Buy and Increased Target to $62 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
David George Maintained (WFC) at Buy and Held Target at $50 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Sprague Downgraded (TT) to Hold and Held Target at $214 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Tessa Romero Maintained (YMAB) at Hold with Decreased Target to $27 on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Hamed Khorsand Upgraded (XPER) to Strong Buy on, Jan 3rd, 2022
[ 12:00 AM ] - WOPRAI
Bascome Majors Maintained (UNP) at Buy with Increased Target to $300 on, Jan 3rd, 2022
Sun, January 2, 2022
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (ULTA) at Buy and Held Target at $480 on, Jan 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (TJX) at Buy and Held Target at $88 on, Jan 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mark Delaney Maintained (TSLA) at Strong Buy on, Jan 2nd, 2022
[ 12:00 AM ] - WOPRAI
Philippe Houchois Maintained (TSLA) at Strong Buy on, Jan 2nd, 2022
Fri, December 31, 2021
[ 12:00 AM ] - WOPRAI
Lauren Lieberman Maintained (STZ) at Buy with Increased Target to $271 on, Dec 31st, 2021
[ 12:00 AM ] - WOPRAI
Kevin Cassidy Maintained (SYNA) at Strong Buy with Increased Target to $345 on, Dec 31st, 2021
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (TFC) at Hold and Held Target at $72 on, Dec 31st, 2021
[ 12:00 AM ] - WOPRAI
Emmanuel Rosner Maintained (TSLA) at Strong Buy with Increased Target to $400 on, Dec 31st, 2021
[ 12:00 AM ] - WOPRAI
Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $5.4 on, Dec 31st, 2021

Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $5.4 on, Dec 31st, 2021


Published on 2024-10-27 19:06:06 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Increased Target from $4.25 to $5.4 on, Dec 31st, 2021.

Oren, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources